Amgen, Inc. (AMGN)
331.70
+2.61
(+0.79%)
USD |
NASDAQ |
May 08, 16:00
332.50
+0.80
(+0.24%)
After-Hours: 20:00
Amgen Market Cap : 179.12B for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.56B |
| Gilead Sciences, Inc. | 163.06B |
| Regeneron Pharmaceuticals, Inc. | 74.95B |
| AbbVie, Inc. | 356.49B |
| Moderna, Inc. | 21.57B |
Market Cap Related Metrics
| PE Ratio | 23.07 |
| PS Ratio | 4.824 |
| PEG Ratio | 0.738 |
| Price to Book Value | 19.49 |
| Price to Free Cash Flow | 20.93 |
| Price | 331.70 |
| Earnings Yield | 4.34% |
| PEGY Ratio | 0.6751 |
| Operating PE Ratio | 15.20 |
| Normalized PE Ratio | 20.83 |